Gene therapy potential for genetic disorders of surfactant dysfunction
AL Cooney, JA Wambach, PL Sinn… - Frontiers in genome …, 2022 - frontiersin.org
Pulmonary surfactant is critically important to prevent atelectasis by lowering the surface
tension of the alveolar lining liquid. While respiratory distress syndrome (RDS) is common in …
tension of the alveolar lining liquid. While respiratory distress syndrome (RDS) is common in …
Alveolar dynamics and beyond–the importance of surfactant protein C and cholesterol in lung homeostasis and fibrosis
K Sehlmeyer, J Ruwisch, N Roldan… - Frontiers in …, 2020 - frontiersin.org
Surfactant protein C (SP-C) is an important player in enhancing the interfacial adsorption of
lung surfactant lipid films to the alveolar air-liquid interface. Doing so, surface tension drops …
lung surfactant lipid films to the alveolar air-liquid interface. Doing so, surface tension drops …
Outcomes of lung transplantation for infants and children with genetic disorders of surfactant metabolism
WB Eldridge, Q Zhang, A Faro, SC Sweet… - The Journal of …, 2017 - Elsevier
Objective To compare outcomes of infants and children who underwent lung transplantation
for genetic disorders of surfactant metabolism (SFTPB, SFTPC, ABCA3, and NKX2-1) over 2 …
for genetic disorders of surfactant metabolism (SFTPB, SFTPC, ABCA3, and NKX2-1) over 2 …
Gene therapeutics for surfactant dysfunction disorders: targeting the alveolar type 2 epithelial cell
Genetic disorders of surfactant dysfunction result in significant morbidity and mortality,
among infants, children, and adults. Available medical interventions are limited, nonspecific …
among infants, children, and adults. Available medical interventions are limited, nonspecific …
Update on diffuse lung disease in children
TJ Vece, LR Young - Chest, 2016 - Elsevier
Diffuse lung diseases in children, also called children's interstitial lung disease, are a
diverse group of rare disorders that cause disturbances of gas exchange in the lungs …
diverse group of rare disorders that cause disturbances of gas exchange in the lungs …
Descriptive and Functional Genomics in Neonatal Respiratory Distress Syndrome: From Lung Development to Targeted Therapies
M Anciuc-Crauciuc, MC Cucerea, F Tripon… - International Journal of …, 2024 - mdpi.com
In this up-to-date study, we first aimed to highlight the genetic and non-genetic factors
associated with respiratory distress syndrome (RDS) while also focusing on the genomic …
associated with respiratory distress syndrome (RDS) while also focusing on the genomic …
Ground glass and fibrotic change in children with surfactant protein C dysfunction mutations
EM DeBoer, DR Liptzin, SM Humphries… - Pediatric …, 2021 - Wiley Online Library
Introduction Therapeutics exist to treat fibrotic lung disease in adults, but these have not
been investigated in children. Defining biomarkers for pediatric fibrotic lung disease in …
been investigated in children. Defining biomarkers for pediatric fibrotic lung disease in …
A novel surfactant protein C gene mutation associated with progressive respiratory failure in infancy
MKS Litao, D Hayes Jr, S Chiwane… - Pediatric …, 2017 - Wiley Online Library
Summary Mutations of the Surfactant Protein C (SPC) gene (SFTPC) have been associated
with childhood interstitial lung disease (chILD) with variable age of onset, severity of lung …
with childhood interstitial lung disease (chILD) with variable age of onset, severity of lung …
Contemporary and emerging technologies for research in children's rare and interstitial lung disease
Although recent decades have seen the identification, classification and discovery of the
genetic basis of many children's interstitial and rare lung disease (chILD) disorders, detailed …
genetic basis of many children's interstitial and rare lung disease (chILD) disorders, detailed …
Systematic review of drug effects in humans and models with surfactant-processing disease
D Klay, TW Hoffman, AM Harmsze… - European …, 2018 - Eur Respiratory Soc
Fibrotic interstitial pneumonias are a group of rare diseases characterised by distortion of
lung interstitium. Patients with mutations in surfactant-processing genes, such as surfactant …
lung interstitium. Patients with mutations in surfactant-processing genes, such as surfactant …